| The MUC1-C oncoprotein as a target in hematologic malignancies. | |
| | |
MedLine Citation:
|
PMID: 20716962 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Jeffrey Schlom |
Publication Detail:
|
Type: Journal Article Date: 2010-09-26 |
Journal Detail:
|
Title: Cancer biology & therapy Volume: 10 ISSN: 1555-8576 ISO Abbreviation: Cancer Biol. Ther. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-11-10 Completed Date: 2011-05-23 Revised Date: 2011-12-21 |
Medline Journal Info:
|
Nlm Unique ID: 101137842 Medline TA: Cancer Biol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 492-4 Citation Subset: IM |
Affiliation:
|
Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. js141c@nih.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cell Differentiation Gene Expression Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*, metabolism, pathology Molecular Targeted Therapy* Mucin-1 / chemistry, genetics, metabolism* Myelopoiesis Prognosis Protein Multimerization |
| Chemical | |
Reg. No./Substance:
|
0/Mucin-1 |
| Comments/Corrections | |
Comment In:
|
Cancer Biol Ther. 2010 Sep;10(5):483-91
[PMID:
20592495
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health.
Next Document: Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.